National Summary Report
Latest data from January 27, 2023
HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
Health Center Program Look-Alike Survey Data for COVID-19
COVID-19 Health Center Survey Interactive Data Dashboards
View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).
View COVID-19 testing data by race/ethnicity.
Note: The dashboard data are updated bi-weekly using Health Center COVID-19 Survey data.
Number of Health Center respondents = 1046 (76% of all Health Centers)
Data represents information provided by health centers funded through H80 grants from a single, specified bi-weekly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 134,321 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 59.66% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 17,848 |
| Racial and/or Ethnic Minority Patients | 61.59% |
Patients Tested by Race and Ethnicity
| Race/Ethnicity | Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 | Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 37.09% | 35.19% |
| White, Hispanic/Latino Patients | 25.50% | 23.97% |
| Black/African American, Non-Hispanic/Latino Patients |
12.61% |
12.61% |
| Black/African American, Hispanic/Latino Patients | 1.11% | 1.36% |
| Asian Patients3 | 2.03% | 3.43% |
| American Indian/Alaska Native Patients3 | 2.35% |
3.04% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.91% | 0.70% |
| Patients with More Than One Race3 | 4.12% | 4.53% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.23% | 6.79% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.65% | 1.93% |
| Unreported/Refused to Report Race and Ethnicity | 6.41% | 6.45% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 12,943 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 81.52% |
| COVID-19 Immunization Series Completed | 12,710 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 82.84% |
| COVID-19 Immunization Series Additional | 61,005 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 77.49% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 16.61% | 15.65% | 20.45% |
| White, Hispanic/Latino Patients | 31.28% | 26.96% | 29.86% |
| Black/African American, Non-Hispanic/Latino Patients | 16.16% |
12.75% |
12.74% |
| Black/African American, Hispanic/Latino Patients | 1.07% | 1.00% | 0.77% |
| Asian Patients3 | 4.82% |
5.48% |
8.47% |
| American Indian/Alaska Native Patients3 | 1.32% | 0.69% | 2.22% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.70% | 1.82% | 1.19% |
| Patients with More Than One Race3 | 4.03% | 2.87% | 4.15% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 12.88% | 23.96% | 11.01% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.65% | 2.96% | 1.77% |
| Unreported/Refused to Report Race and Ethnicity | 7.47% | 5.87% | 7.37% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 27.53% |
| 1 to 24 Hours | 34.42% |
| More Than 24 Hours | 34.51% |
| N/A | 3.54% |
Operations and Staff
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) | 22.18% |
| Number of Community-Based Events | 1,258 |
| Number of Collaboration Community-Based Events | 445 |
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 27.44% |
Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Number of Doses of Monoclonal Antibodies Administered | 431 |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 58.60% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 263,820 |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask | 23.33% |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 91,489 |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 24.76% |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | 57.31% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 31.87% |
| White, Hispanic/Latino Patients | 24.33% |
| Black/African American, Non-Hispanic/Latino Patients | 10.79% |
| Black/African American, Hispanic/Latino Patients | 1.90% |
| Asian Patients3 | 9.25% |
| American Indian/Alaska Native Patients3 | 0.98% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.75% |
| Patients with More Than One Race3 | 1.84% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.48% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
1.90% |
| Unreported/Refused to Report Race and Ethnicity | 8.92% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 1.57% |
| Patients Experiencing Homelessness | 2.20% |
| Patients Who Are Residents of Public Housing | 10.59% |
| Patients with Limited English Proficiency |
16.13% |
| Children Under 18 Years of Age | 1.77% |
Results from States and Territories
Select a measure on the dropdown menu to view by state or territory.
1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.